Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-418101

General Counsel and Secretary sold 1,990 shares at $60.04 ($119,481)

  • General Counsel and Secretary acquired 1,990 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

KASINGER JAMES R. · General Counsel and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-06 Exercise or conversion : show line 1 in the form 10b5-1 +1,990 $13.62 $27,104 96,774 D
2026-10-06 Sale : show line 2 in the form 10b5-1 −1,990 $60.04 $119,481 94,784 D
Open-market sales · 1,990 sh · avg $60.04 · $119,481

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-06 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −1,990 81,242 D
Loading xslF345X06/ownership.xml…